Business

Notice of Interim Results & Investor Presentation

Notice of Interim Results & Investor Presentation.

articleEkf Diagnostics Holdings PlcSeptember 1, 20225/company/ekf-diagnostics-holdings-plc/news/notice-of-interim-results-and-investor-presentation-29
Notice of Interim Results & Investor Presentation

About this update from Ekf Diagnostics Holdings Plc

[{"type":"text","content":"\n \n \n \n EKF Diagnostics Holdings plc\n \n \n \n (\"EKF\", the \"Company\" or the \"Group\")\n \n \n \n  \n \n \n \n \n Notice of Interim Results & Investor Presentation\n \n \n \n  \n \n \n Notice of Results\n \n \n EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed\n global diagnostics business\n , confirms that the Company will\n announce its interim results for the six months ended 30 June 2022 on Tuesday 20 September 2022.\n \n \n  \n \n \n Investor Presentation\n \n \n Mike Salter, Chief Executive Officer, and Marc Davies, Chief Financial Officer, will be hosting a live online presentation relating to the interim results via the Investor Meet Company platform at 4.30 pm on Tuesday 20 September 2022. The presentation is open to all existing and potential investors.\n \n \n  \n \n \n Investors can sign up to Investor Meet Company for free and register for the presentation here: \n \n https://www.investormeetcompany.com/ekf-diagnostics-holdings-plc/register-investor\n \n \n \n  \n \n \n Investors who already follow EKF on the Investor Meet Company platform will automatically be invited.\n \n \n  \n \n \n Questions can be submitted pre-event via your IMC dashboard or in real time during the presentation, via the \"Ask a Question\" function. Whilst the Company may not be in a position to answer every question it receives, it will address the most prominent within the confines of information already disclosed to the market through regulatory notifications. A recording of the presentation, a PDF of the slides used, and responses to the Q&A session will be available on the Investor Meet Company platform afterwards.\n \n \n  \n \n \n  \n \n \n \n \n \n \n \n EKF Diagnostics Holdings plc\n \n \n \n \n \n \n \n www.ekfdiagnostics.com\n \n \n \n \n \n \n \n \n Mike Salter, CEO /\n Marc Davies, CFO\n \n \n \n \n  Tel:\n +44 (0)29 2071 0570\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Singer Capital Markets (Nominated Adviser & Joint Broker)\n \n \n \n \n Tel: +44 (0)20 7496 3000\n \n \n \n \n \n \n Aubrey Powell / George Tzimas\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Investec Bank plc (Joint Broker)\n \n \n \n \n \n Tel: +44 (0)20 7597 4000\n \n \n \n \n \n \n Gary Clarence / Daniel Adams...

More updates from Ekf Diagnostics Holdings Plc